EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis

Ei Shiomi iD, Yuta Goto, Mizuki Hisano iD, Rento Ito, Makoto Moriwaka, Daiki Ikarashi iD, Shigekatsu Maekawa iD, Renpei Kato, Mitsugu Kanehira iD, Takashi Ujiie, Wataru Obara iD

IJU Case Reports · 2024-03 · 7 (2) · 148-151

DOI: 10.1002/iju5.12689 ↗

Kurz gefasst

Fallbericht in der Zeitschrift IJU Case Reports, online erschienen am 09.01.2024. Verfasst von Ei Shiomi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Iwate Medical University Yahaba Iwate Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Combination therapies of immune checkpoint and tyrosine kinase inhibitors for end‐stage kidney disease and patients on hemodialysis need careful consideration as few case reports provide suitable management decisions. Case presentation A 70‐year‐old man who had undergone hemodialysis for 6 years due to nephrosclerosis. Avelumab plus axitinib combination therapy was performed for repeated lung metastasis, and a complete response was achieved without major side effects.

Conclusion

A complete response was achieved after Ave plus Axi combination therapy for clear cell renal cell carcinoma in a patient undergoing dialysis. This suggests that Ave plus Axi combination therapy may be safe and effective for dialysis patients.

Schlagwörter

Stichwörter der Autor:innen

avelumabaxitinibcarcinomaimmune checkpoint inhibitorsrenal cellrenal dialysis

Autor:innen und Institutionen

  • Department of Urology Iwate Medical University Yahaba Iwate Japan.
  • Department of Urology Iwate Prefectural Ofunato Hospital Ofunato Iwate Japan.

ORCID-Profile: Ei Shiomi, Mizuki Hisano, Daiki Ikarashi, Shigekatsu Maekawa, Mitsugu Kanehira, Wataru Obara

Zitieren

APA

Shiomi, E., Goto, Y., Hisano, M., Ito, R., Moriwaka, M., Ikarashi, D., Maekawa, S., Kato, R., Kanehira, M., Ujiie, T., & Obara, W. (2024). A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis. IJU Case Reports, 7(2), 148-151. https://doi.org/10.1002/iju5.12689

Vancouver

Shiomi E, Goto Y, Hisano M, Ito R, Moriwaka M, Ikarashi D, et al. A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis. IJU Case Reports. 2024;7(2):148-151. doi:10.1002/iju5.12689

BibTeX
@article{Shiomi2024,
  author = {Shiomi, Ei and Goto, Yuta and Hisano, Mizuki and Ito, Rento and Moriwaka, Makoto and Ikarashi, Daiki and Maekawa, Shigekatsu and Kato, Renpei and Kanehira, Mitsugu and Ujiie, Takashi and Obara, Wataru},
  title = {A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis},
  journal = {IJU Case Reports},
  year = {2024},
  volume = {7},
  number = {2},
  pages = {148--151},
  doi = {10.1002/iju5.12689}
}
Kostenlos starten →